An Appraisal and Update of Fluorodeoxyglucose and Non-Fluorodeoxyglucose-PET Tracers in Thyroid and Non–Thyroid Endocrine Neoplasms

A Adnan, S Raju, R Kumar, S Basu - PET clinics, 2022 - pet.theclinics.com
Endocrine neoplasms and malignancies are a group of tumors with varied clinical,
histopathologic, and functional features. These tumors may vary from sporadic to hereditary …

Role of fluorodeoxyglucose PET/computed tomography in targeted radionuclide therapy for endocrine malignancies

DA Pattison, MS Hofman - PET clinics, 2015 - pet.theclinics.com
The role of FDG PET/CT in the management of endocrine malignancies has evolved over
the last 15 years with increasing clinical experience and greater understanding of the …

[HTML][HTML] New PET radiotracers for the imaging of neuroendocrine neoplasms

E Fortunati, G Argalia, L Zanoni, S Fanti… - … treatment options in …, 2022 - Springer
Opinion statement Neuroendocrine neoplasms (NEN) are a heterogeneous group of
tumours derived from cells of neuroendocrine origin and can potentially arise everywhere in …

Functional imaging of endocrine tumors: role of positron emission tomography

K Pacak, G Eisenhofer, DS Goldstein - Endocrine Reviews, 2004 - academic.oup.com
This article provides an update on functional imaging approaches for diagnostic localization
of endocrine tumors, with emphasis on positron emission tomography (PET).[18F] …

PET imaging for endocrine malignancies: from woe to go

D Taïeb, RJ Hicks, K Pacak - Journal of Nuclear Medicine, 2017 - Soc Nuclear Med
123I, 99mTc-sestamibi, 111In-pentetreotide, and 123/131I-metaiodobenzylguanidine were
the only scintigraphic techniques available for imaging specific tumor types, but their …

PET and PET/CT in endocrine tumours

R Dudczak, T Traub-Weidinger - European journal of radiology, 2010 - Elsevier
Functional information provided by PET tracers together with the superior image quality and
the better data quantification by PET technology had a changing effect on the significance of …

Endocrine tumors: the evolving role of positron emission tomography in diagnosis and management

M Naji, M Hodolic, S El-Refai, S Khan… - Journal of …, 2010 - Springer
Endocrine tumors comprise a range of benign and malignant conditions that produce a
spectrum of clinical symptoms and signs depending on the specific hormones they produce …

Role of positron emission tomography/computed tomography in adrenal and neuroendocrine tumors: fluorodeoxyglucose and nonfluorodeoxyglucose tracers

KK Wong, M Arabi, I Zerizer, A Al-Nahhas… - Nuclear medicine …, 2011 - journals.lww.com
Positron emission tomography (PET) has seen an increasing clinical utilization in the last
decade, such that it is now a standard oncology imaging modality. Its success is based on …

PET and PET/CT imaging in thyroid and adrenal diseases: an update

G Treglia, L Giovanella, V Rufini - Hormones, 2013 - Springer
Positron emission tomography (PET) and PET/computed tomography (PET/CT) with different
tracers are imaging methods increasingly used in patients with thyroid and adrenal …

The Role of 18F‐Fluorodeoxyglucose Positron Emission Tomography in Thyroid Neoplasms

BHH Lang, TT Law - The Oncologist, 2011 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to:
Evaluate and apply evidence regarding the use of FDG‐PET scans in patients with thyroid …